We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
N-Acetyl-seryl-aspartyl-lysyl-proline Alleviates Renal Fibrosis Induced by Unilateral Ureteric Obstruction in BALB/C Mice.
- Authors
Chan, Gary C. W.; Yiu, Wai Han; Wu, Hao Jia; Wong, Dickson W. L.; Lin, Miao; Huang, Xiao Ru; Lan, Hui Yao; Tang, Sydney C. W.
- Abstract
To expand the armamentarium of treatment for chronic kidney disease (CKD), we explored the utility of boosting endogenously synthesized N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP), which is augmented by inhibition of the angiotensin converting enzyme. Male BALB/c mice underwent unilateral ureteral ligation (UUO) or sham operation and received exogenously administered Ac-SDKP delivered via a subcutaneous osmotic minipump or Captopril treatment by oral gavage. Seven days after UUO, there were significant reductions in the expression of both collagen 1 and collagen 3 in kidneys treated with Ac-SDKP or Captopril, and there was a trend towards reductions in collagen IV, α-SMA, and MCP-1 versus control. However, no significant attenuation of interstitial injury or macrophage infiltration was observed. These findings are in contrary to observations in other models and underscore the fact that a longer treatment time frame may be required to yield anti-inflammatory effects in BALB/c mice treated with Ac-SDKP compared to untreated mice. Finding an effective treatment regimen for CKD requires fine-tuning of pharmacologic protocols.
- Subjects
RENAL fibrosis; URETERIC obstruction; KIDNEY disease treatments; LABORATORY mice; ANGIOTENSIN converting enzyme; TUBE feeding; DIAGNOSIS; THERAPEUTICS
- Publication
Mediators of Inflammation, 2015, Vol 2015, p1
- ISSN
0962-9351
- Publication type
Article
- DOI
10.1155/2015/283123